US
US NAD+ Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $263.8 Mn.
Canada at 10.8% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$313.9 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $241.8 Mn | — | — |
| 2025 (base) | $263.8 Mn | +$22.0 Mn | — |
| 2026 (forecast) | $287.8 Mn | +$24.0 Mn | +9.1% |
| 2027 (forecast) | $314.0 Mn | +$26.2 Mn | +19% |
| 2028 (forecast) | $342.5 Mn | +$28.6 Mn | +29.9% |
| 2029 (forecast) | $373.7 Mn | +$31.2 Mn | +41.7% |
| 2030 (forecast) | $407.7 Mn | +$34.0 Mn | +54.6% |
| 2031 (forecast) | $444.8 Mn | +$37.1 Mn | +68.6% |
| 2032 (forecast) | $485.3 Mn | +$40.5 Mn | +84% |
| 2033 (forecast) | $529.4 Mn | +$44.2 Mn | +100.7% |
| 2034 (forecast) | $577.6 Mn | +$48.2 Mn | +119% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$263.8 Mn
Canada
$53.5 Mn
China
$53.2 Mn
Japan
$41.0 Mn
Germany
$19.5 Mn
France
$17.5 Mn
UK
$17.1 Mn
Brazil
$14.5 Mn
Ecuador
$13.9 Mn
Spain
$12.7 Mn
Italy
$12.7 Mn
India
$13.0 Mn
Saudi Arabia
$12.0 Mn
Mexico
$10.6 Mn
Australia
$8.1 Mn
Russia
$5.8 Mn
New Zealand
$5.3 Mn
South Africa
$4.4 Mn
UAE
$3.4 Mn
Egypt
$1.7 Mn
Philippines
$1.2 Mn
Hong Kong
$1.1 Mn
Malaysia
$0.9 Mn
Singapore
$0.9 Mn
Thailand
$0.7 Mn
Kenya
$0.5 Mn
NAD+ supplements, such as NMN and nicotinamide riboside, aim to raise levels of NAD+, a molecule linked to cell energy that falls with age.
Key segments of the NAD+ Supplements market include ingredient (Nicotinamide Riboside, NMN and NAD+ Direct) and form (Capsules, Powders and IV and Injections).
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the NAD+ Supplements market. Older adults and their families are spending more on staying active and independent.
Preventive care, personalised plans based on biomarkers and home-based services give the NAD+ Supplements market room to grow, especially in fast-ageing countries in Asia and Europe.
Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the NAD+ Supplements market.
The NAD+ Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Food and supplement rules, labelling and health-claim regulations govern NAD+ Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in US.
What doctors and scientists are doing in NAD+ Supplements right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
US · 2 shared keywords
US · 2 shared keywords
US · 2 shared keywords
US · 2 shared keywords
US · 2 shared keywords
US · 2 shared keywords
Healthcare Services · US
Digital Health · US
Pharmaceuticals · US
Medical Devices · US
Medical Devices · US
Medical Devices · US